What is WGS's current stock price?

WGS (GeneDx Holdings Corp.) is currently trading at $49.44 with a market cap of $1.47B.

What sector is GeneDx Holdings Corp. in?

GeneDx Holdings Corp. (WGS) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.

Is WGS a good stock to buy?

Analysts have a Buy consensus on WGS with a price target of $96.43. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

WGS GeneDx Holdings Corp.

Healthcare

$49.44+4.50%ClosedMarket Cap: $1.47B

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

5.46

P/S

3.17

EV/EBITDA

-30.49

DCF Value

$-165.40

FCF Yield

-2.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

68.3%

Operating Margin

-7.7%

Net Margin

-17.6%

ROE

-27.5%

ROA

-15.4%

ROIC

-8.1%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$102.3M	$-63.3M	$—
Q4 null	$121.0M	$-17.7M	$—
FY null	$427.5M	$-21.0M	$—
Q3 null	$116.7M	$-7.6M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$96.43

Target (Median)

$85.00

Target Range

$70.00 - $150.00

1 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Canaccord GenuityBuy

2026-05-05

GuggenheimBuy

2026-05-05

BTIGBuy

2026-05-05

Wells FargoOverweight

2026-05-05

GuggenheimBuy

2026-03-30

Trading Activity

Insider Trades

View All

Casdin Capital, LLCdirector, 10 percent owner:

BuyWed May 20

Casdin Capital, LLCdirector, 10 percent owner:

BuyWed May 20

Casdin Capital, LLCdirector, 10 percent owner:

BuyWed May 20

Meister Keith A.director, 10 percent owner:

BuyFri May 15

Meister Keith A.director, 10 percent owner:

BuyFri May 15

Related AI Research

Insider BuyMay 12, 2026

Meister Keith A. buys $10.0M of WGS

Meister Keith A.

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

Exchange

—

Beta

2.07

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Peers